Y. Yasutomo

发表

Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures.

N. Kugai, N. Nagata, T. Akatsu, 1996, Bone.

Changes of bone metabolic markers in patients with bone metastases: clinical significance in assessing bone response to chemotherapy.

N. Kugai, N. Nagata, S. Wada, 1993, Internal medicine.

Simultaneous occurrence of SIADH, secondary hypogonadism and alopecia universalis in a woman with IDDM.

N. Kugai, N. Nagata, M. Noritake, 1991, Endocrinologia japonica.

Patients with renal hypouricemia with exercise-induced acute renal failure and chronic renal dysfunction.

K. Tomita, H. Nonoguchi, S. Takebayashi, 2000, Clinical nephrology.

[Parathyroid hormone and calcitonin].

Y. Yasutomo, N. Nagata, 1992, Nihon rinsho. Japanese journal of clinical medicine.

Non-cushingoid Cushing's syndrome due to adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia.

N. Kugai, N. Nagata, S. Terahata, 1995, Internal medicine.

The tumor cells (FA-6) established from a pancreatic cancer associated with humoral hypercalcemia of malignancy: a simultaneous production of parathyroid hormone-like activity and transforming growth factor activity.

T. Shimauchi, N. Kugai, N. Nagata, 1989, Endocrinologia japonica.

Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid.

S. Tanaka, N. Kugai, N. Nagata, 1990, Cancer research.

Purification and partial sequencing of inhibitory factor on renal membrane adenylate cyclase in pancreatic cancer extract: identity with histones H1b or H1d.

T. Suga, K. Takishima, G. Mamiya, 1991, Biochemical and biophysical research communications.

Inhibition of renal membrane adenylate cyclase by extract of pancreatic cancer associated with humoral hypercalcemia of malignancy.

N. Kugai, N. Nagata, O. Takatani, 1990, Bone and mineral.